AJCP / Meeting AbstrActs group included embryonal rhabdomyosarcoma, epithelioid sarcoma, osteosarcoma, chondrosarcoma, malignant peripheral nerve sheet tumor, Ewing sarcoma, dedifferentiated liposarcoma, synovial sarcoma, fibrosarcoma, and pleomorphic undifferentiated sarcoma. p16 immunostain was performed on all of the cases, and HPV-PCR was performed on 16 cases with available material (six sarcomatoid SCC, nine mesenchymal tumors, and one poorly differentiated malignant neoplasm). Results: p16 was positive in 17/21 (61%) mesenchymal tumors and five of 28 (24%) sarcomatoid carcinomas. Interestingly, all of the HPV-PCRs were negative. Conclusion: Our preliminary studies show that HPV is not prevalent in sarcomatoid carcinoma and mesenchymal tumors of the head and neck. Interestingly, p16 expression is more common in mesenchymal tumors than in sarcomatoid carcinomas (P = .02). Our next step is to test additional cases of mesenchymal tumors and sarcomatoid carcinomas for HPV. We will also correlate p16 status with survival data.
Objectives: Congenital hepatic fibrosis (CHF) is predominantly an autosomal recessive disease caused by ductal plate malformation of intrahepatic small bile duct branches. Most common disease associations of CHF include autosomal recessive polycystic kidney disease (ARPKD) and Caroli disease. Less common associations include Meckel-Gruber syndrome, June syndrome, and Bardet-Biedl syndrome. We studied the clinicopathologic features of this relatively rare condition during adulthood, Methods: Five cases with confirmed clinicopathologic diagnosis of CHF were identified in the archives (2010) (2011) (2012) (2013) (2014) (2015) (2016) , including three liver core biopsies and two resections. A detailed morphologic analysis was performed and clinical data were obtained from electronic medical records. Results: Patients' median age at diagnosis is 46.6 years (range, 26-69 years). Male to female ratio is 3:2. Clinical manifestations are quite variable, ranging from being asymptomatic with mildly elevated liver enzymes to full-blown hepatic encephalopathy requiring liver transplant. One case has associated Caroli disease, one case has concomitant polycystic kidney disease and congenital anomaly of hepatic vasculature, one case has associated Caroli disease and ARPKD, and the remaining two cases have no other disease association. Histologically, all cases show prominent small interlobular bile ductular proliferation. Eighty percent of cases have fibrosis limited to portal/periportal areas, and only one case has well established liver cirrhosis (trichrome stain). Significant portal inflammation, steatosis, steatohepatitis, and hepatocellular necrosis are not evident. Portal vein branches are inconspicuous in 80% of cases. Conclusion: CHF is a congenital fibropolycystic disorder characterized by hepatic ductal plate malformation. Common clinical presentations are portal hypertension and normal/near normal liver enzymes. Histologic differential diagnoses include other biliary diseases with portal fibrosis, idiopathic non-cirrhotic portal hypertension, and von Meyenburg complexes. Despite helpful morphologic features (anastomosing biliary channels in irregular fibrous portal tracts) to suspect diagnosis of congenital hepatic fibrosis in biopsies, a multidisciplinary diagnostic approach by pathologists, radiologists, and hepatologists is crucial for accurate evaluation. 
Introduction:
The nature of inverted follicular keratoses (IFKs) is disputed, with some suggesting that they represent a variant of verruca or seborrheic keratosis. While both verruca and genital seborrheic keratoses have been associated with human papillomavirus (HPV), no HPV association has been reported in extragenital IFKs. Furthermore, vulvar IFKs have not been separately examined for HPV. We aimed to detect and compare the type-distribution of high-risk HPVs (hrHPVs) in vulvar and extragenital IFKs using a PCR-based detection method. Methods: Vulvar and extragenital IFKs from 2014 to 2016 from patients without prior history of HPV-associated lesions were identified and reviewed. Cases with greater than 90% lesional tissue were selected for DNA extraction and assessed for adequate DNA yield. Each case was assayed using the GeneNav HPV One kit (GenomeMe, Richmond, BC, Canada) for HPV16 and HPV18 with nonspecific detection of other hrHPVs. Cases demonstrating other hrHPV types were genotyped using the GeneNav HPV genotyping kit. Immunohistochemical staining for p16 and Ki67 was also performed. Results: Twenty-six cases including four vulvar IFKs (4/26, 15.4%) meeting study criteria were identified.
